Cardiomyopathy: Experiences of Diagnosis

  • Research type

    Research Study

  • Full title

    Cardiomyopathy: Exploring Patients' and Clinicians' Experiences of Diagnosis

  • IRAS ID

    215198

  • Contact name

    Jennifer Rees

  • Contact email

    J.L.Rees@2016.ljmu.ac.uk

  • Sponsor organisation

    Liverpool John Moores University

  • Duration of Study in the UK

    1 years, 8 months, 28 days

  • Research summary

    Title: Cardiomyopathy: Exploring Clinicians’ and Patients’ Experiences of Diagnosis

    Purpose:
    Cardiomyopathies are a range of disorders characterised by structural and functional abnormalities of the heart muscle. As a major cause of morbidity and mortality, cardiomyopathies represent a significant global burden and are the leading cause of sudden death in people under the age of 35. The diagnosis process requires further exploration as, at present, the diagnostic pathway is unclear and can often vary between patients. Similarly, little is known about the lived experiences of newly diagnosed cardiomyopathy patients, or their adjustment to life following diagnosis. This study will provide new insight into the cardiomyopathy diagnostic process through a combination of perspectives.

    Participants:
    Adult NHS patients with a recent diagnosis of cardiomyopathy will be recruited alongside clinicians caring for cardiomyopathy patients.

    Methodology:
    The study will use a sequential explanatory design with multiple phases (Creswell and Clark 2007). Phase 1 will explore clinicians’ experiences of the diagnostic process using semi-structured interviews. Phase 2 will use a series of validated questionnaires to assess the patients’ quality of life (Green et al. 2000) and psychological wellbeing (Zigmond and Snaith 1983) during the early stages of diagnosis. Using semi-structured interviews, phase 3 will explore the same patients’ experiences of diagnosis, and the implications of living with cardiomyopathy. Follow-up interviews will be conducted 6 months later during Phase 4, to explore the longitudinal impact of the diagnosis.

    Implications:
    This study is expected to highlight the needs of newly diagnosed cardiomyopathy patients and that of their clinicians, with a view to improving services.

  • REC name

    HSC REC B

  • REC reference

    17/NI/0099

  • Date of REC Opinion

    7 Jun 2017

  • REC opinion

    Further Information Favourable Opinion